Dr. Michael Alan Fischman, MD

Dr. Fischman practices at DaVita Nephron Dialysis in Long Beach, California.

Dr. Fischman's NPI, 1710326558, was assigned on June 14, 2013. Dr. Fischman graduated from St. George's University School of Medicine in 2013. Dr. Fischman holds California license A155691.

Dr. Fischman's primary practice is DaVita Nephron Dialysis, at 5820 Downey Avenue, Long Beach, CA 90805 in Los Angeles County. The practice phone is (562) 663-0788.

Dr. Fischman's primary practice is DaVita Nephron Dialysis in Long Beach, California. Dr. Fischman is also affiliated with Long Beach Medical Center. The medical group on file is Southland Renal Medical Group. Dmand AI also links Dr. Fischman to 4 more hospitals, 4 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fischman practices, 11 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Fischman's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Fischman is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Fischman's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia and kidney stones among the conditions Dr. Fischman treats.

CMS data shows 1,765 Medicare services from Dr. Fischman across 10 procedure codes in 2024, for 419 Medicare patients. Medicare paid $234,519 for them.

CMS counts 419 Medicare patients who saw Dr. Fischman in 2024. The largest group is 65 to 74, with 154 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 79% are also on Medicaid. Their average risk score is 5.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fischman's median patient age at 67, with 45% women.

In 2024, Dr. Fischman wrote 789 Medicare Part D claims for 158 patients. 83% of them were for generic drugs. CMS names the drug for 596 of them, across 17 drugs with 11 or more claims each, at $140,565 in total drug cost. In 2023, CMS named 417 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Fischman for performance year 2024, reported individually. Dr. Fischman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Fischman in 2023. The most frequent topics are Occupational Exposure and Occupational Health. Dr. Fischman has published most often in J Occup Environ Med. Dr. Fischman's most frequent co-authors are Michael Lawrence Fischman, MD, Michael J. Kosnett, MD, MPH and Manijeh Berenji, MD.

CMS Open Payments shows 22 general payments to Dr. Fischman from 11 drug and device companies from 2019 to 2024. Consulting fees make up the largest share, 50% of the total. Fresenius USA Marketing, Inc. paid the most, $3,991.

Dr. Fischman graduated from St. George's University School of Medicine in 2013.

Dr. Fischman is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.